(-)-Syringaresinol

(-)-Syringaresinol
Product Name (-)-Syringaresinol
CAS No.: 6216-81-5
Catalog No.: CFN92500
Molecular Formula: C22H26O8
Molecular Weight: 418.4 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Powder
Targets: Cdk | p21 | Bcl-2/Bax | Caspase | PARP | P450 (e.g. CYP17)
Source: The rhizomes of Polygonatum kingianum
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $268/10mg
(-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-60 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • J Biomol Struct Dyn.2023, 1-21.
  • J Med Chem.2023, 66(6):4106-4130.
  • International Food Research Journal2018, 25(6):2560-2571
  • Sci Rep.2017, 7:46299
  • J Nat Med.2017, 71(2):380-388
  • Nutrients2020, 12(2):488
  • J. of Agricultural Science2015, 1916-9760
  • Braz J Med Biol Res.2021, 54(12):e11183.
  • Biomedicine & Pharmacotherapy2022, 153:113404.
  • Arabian Journal of Chemistry2024, 17(3):105648
  • (-)-Asarinin

    Catalog No: CFN90144
    CAS No: 133-04-0
    Price: $128/20mg
    (-)-Epipinoresinol

    Catalog No: CFN92420
    CAS No: 10061-38-8
    Price: Inquiry(manager@chemfaces.com)
    Phillygenin

    Catalog No: CFN90511
    CAS No: 487-39-8
    Price: $118/20mg
    Phillyrin

    Catalog No: CFN99998
    CAS No: 487-41-2
    Price: $30/20mg
    (+)-Mediresinol Di-O-beta-D-glucopyranoside

    Catalog No: CFN91840
    CAS No: 88142-63-6
    Price: $318/5mg
    Fargesin

    Catalog No: CFN98174
    CAS No: 31008-19-2
    Price: $40/20mg
    Asarinin

    Catalog No: CFN90628
    CAS No: 133-05-1
    Price: $138/20mg
    Eleutheroside D

    Catalog No: CFN98510
    CAS No: 79484-75-6
    Price: $368/10mg
    Eleutheroside E

    Catalog No: CFN99984
    CAS No: 39432-56-9
    Price: $50/20mg
    (-)-Pinoresinol

    Catalog No: CFN92287
    CAS No: 81446-29-9
    Price: $268/5mg
    Int Immunopharmacol. 2008 Jul;8(7):967-73.
    (-)-Syringaresinol inhibits proliferation of human promyelocytic HL-60 leukemia cells via G1 arrest and apoptosis.[Pubmed: 18486907]
    We examined the effect of (-)-Syringaresinol, a furofuran-type lignan isolated from Daphne genkwa, on cell cycle regulation in HL-60 human promyelocytic leukemia cells in vitro.
    METHODS AND RESULTS:
    (-)-Syringaresinol decreased the viability of HL-60 cells by inducing G(1) arrest followed by apoptosis in a dose- and time-dependent manner. The G(0)/G(1) phase of the cell cycle is regulated by cyclin-dependent kinases (Cdk), cyclins and cyclin-dependent kinase inhibitors (Cdki). We show by western blot analysis, that the (-)-Syringaresinol-induced G(1) arrest was mediated through the increased expression of Cdki proteins (p21(cip1/waf1) and p27(kip1)) with a simultaneous decrease in cdk2, cdk4, cdk6, cyclin D(1), cyclin D(2), and cyclin E expression. The induction of apoptosis after treatment with (-)-Syringaresinol for 24 h was demonstrated by morphological changes, DNA fragmentation, altered ratio of Bax/Bcl-2, cleavage of poly(ADP-ribose) polymerase and flow cytometry analysis. (-)-Syringaresinol also induced cytochrome c release and activation of caspase-3 and caspase-9. To our knowledge, this is the first time that (-)-Syringaresinol has been reported to potently inhibit the proliferation of human promyelocytic HL-60 cells through G(1) arrest and induction of apoptosis.
    CONCLUSIONS:
    These findings suggest that (-)-Syringaresinol may be a potential chemotherapeutic agent for the treatment of cancer.
    Fargesol

    Catalog No: CFN95027
    CAS No: 128855-64-1
    Price: $318/20mg
    Polygalasaponin XLIX

    Catalog No: CFN95117
    CAS No: 1033593-12-2
    Price: $318/10mg
    13(S)-Hydroxyoctadeca-9(Z),11(E)-dienoic acid (13-HODE)

    Catalog No: CFN95307
    CAS No: 18104-45-5
    Price: $318/10mg
    Theaflavanoside II

    Catalog No: CFN95380
    CAS No: 943785-09-9
    Price: $318/5mg
    Maingayone

    Catalog No: CFN95479
    CAS No: 271585-66-1
    Price: $318/10mg
    Bayin

    Catalog No: CFN95539
    CAS No: 3681-96-7
    Price: $318/5mg
    Calleryanin

    Catalog No: CFN95556
    CAS No: 20300-53-2
    Price: $318/5mg
    Protocatechuic acid 4-O-beta-glucoside

    Catalog No: CFN95557
    CAS No: 7361-59-3
    Price: $413/5mg
    Taxezopidine H

    Catalog No: CFN95562
    CAS No: 205440-23-9
    Price: $318/5mg
    Irigenin 3'-O-glucoside

    Catalog No: CFN95578
    CAS No: N/A
    Price: $318/5mg